US Stock MarketDetailed Quotes

CANF Can-Fite BioPharma

Watchlist
  • 2.2000
  • +0.1000+4.76%
Close Nov 29 13:00 ET
  • 2.2300
  • +0.0300+1.36%
Post 15:55 ET
13.41MMarket Cap-846P/E (TTM)

Can-Fite BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Can-Fite BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 150.000K--
--2024/Q1-- / 150.000K--
--2023/Q4155.000K / 200.000K--
--2023/Q3196.000K / 200.000K--
--2023/Q2196.000K / 200.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 150.000K--
--2024/Q1-- / 150.000K--
--2023/Q4155.000K / 200.000K--
--2023/Q3196.000K / 200.000K--
--2023/Q2196.000K / 200.000K--

Unlock Free Earnings Estimates

Can-Fite BioPharma Earnings Reports

  • Can-Fite BioPharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 30 16:24 ET

  • Can-Fite BioPharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 29 08:50 ET

  • Can-Fite BioPharma | 6-K/A: Report of foreign private issuer (related to financial reporting)

    Jun 7 16:20 ET

  • Can-Fite BioPharma | 6-K: Report of foreign private issuer (related to financial reporting)

    May 22 16:20 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 12, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data